A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

NCT05235542 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: AK104
DRUG: AK117
DRUG: Capecitabine tablets
DRUG: Oxaliplatin
DRUG: Cisplatin
DRUG: Paclitaxel
DRUG: Irinotecan
DRUG: Docetaxel
DRUG: 5-FU

Sponsor

Akeso